San Antonio, Texas USA (UroToday.com) Accountable Care Organizations (ACO’s) represent the potential future structure of medical care in the United States. Most ACO’s are developed with primary care specialties at the center, but the incorporation of specialty care is managed variably based on the existence of small single specialty, large single specialty, or multispecialty group practices that the ACO covers.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The authors therefore concluded that prostate cancer patients aligned with ACOs had similar treatment rates but higher treatment costs, especially in the context of single-specialty groups. This is a crucial point. The development of the ACO model was primarily intended to model a healthcare home for patients around their primary-care needs. The model for incorporating surgical specialties has not been well-defined. Bringing in specialists may help to ramp down costs. For better or for worse, treatment rates have not changed in the 2 years following ACOs, so at least we know patients are likely getting appropriate care.
Authors: Amy Luckenbaugh, Samuel Kaufman, Phyllis Yan, Tudor Borza, Lindsey Herrel, David Miller, Vahakn Shahinian, and Brent Hollenbeck
University of Michigan
Written By: Shreyas Joshi, M.D., Fox Chase Cancer Center
17th Annual Meeting of the Society of Urologic Oncology - November 30 -December 2, 2016 – San Antonio, Texas USA